Extension Agreement to Exchange Agreement between Guided Therapeutics, Inc. and Auctus Fund, LLC
Guided Therapeutics, Inc. and Auctus Fund, LLC have agreed to extend the deadline for completing an "Uplist Offering" under their existing Exchange Agreement. Originally set to expire on December 31, 2021, the new termination date is now April 15, 2022. This extension does not change any other terms of the original agreement. Both parties have signed to confirm their acceptance of this new deadline.
EXHIBIT 10.88
GUIDED THEREAPEUTICS, INC.
|
|
| February 10, 2022 |
Auctus Fund, LLC
|
| Re: | Extension of Termination Date |
Dear Holder:
Reference is made to that certain Exchange Agreement, dated as of June 2, 2021 (the “Agreement”) made by Guided Therapeutics, Inc. (the “Company’’) and Auctus Fund, LLC (“Auctus”). Section 3(c) of the Agreement provides, in part, that the obligations under the Agreement shall be null and void if the “Uplist Offering” does not occur by December 31, 2021. Consistent with the Exchange Agreement, dated February 1, 2022 by and among the Company and Auctus, Auctus hereby extends the termination date to April 15, 2022. This Agreement is limited as specified herein and the execution, delivery and effectiveness of this Agreement shall not operate as a modification or waiver of any provision of the Agreement except as expressly set forth herein.
|
| Sincerely, |
| |
|
|
|
|
|
|
| Guided Therapeutics, Inc. |
| |
|
|
|
|
|
|
| By: |
|
|
|
|
|
|
|
|
| Name: |
|
|
|
|
|
|
|
|
| Title: | President & CEO |
|
Accepted and agreed to:
Auctus Fund, LLC
By:
Name: Lou Posner
Title: Managing Director
